West Nile - Innovator

Manufacturer: Fort Dodge

West Nile Virus Vaccine

Killed Virus

West Nile - Innovator Indications

For the vaccination of healthy horses as an aid in the prevention of viremia caused by West Nile Virus. Efficacy was demonstrated in horses that received two doses of the vaccine and were challenged one year post-vaccination with West Nile Virus. The vaccine protected 95% of the vaccinates against infection, while 82% of the controls were viremic.

Owners should be advised that vaccinated horses may develop antibody to West Nile Virus, which may affect their ability to export the animal.

Dose

Inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 6 weeks after the first dose. Revaccinate annually with one 1 mL dose.

West Nile - Innovator Caution

Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.

Thimerosal, neomycin and polymyxin B added as preservatives.

For Veterinary Use Only

U.S. Pat. No. 7,153,513 and patents pending

© 2007 Fort Dodge Animal Health. All Rights Reserved.

Fort Dodge Animal Health, Fort Dodge, Iowa 50501 Usa

U.S. Vet. License No. 112

12 x 1 mL syringes		16661H
10 x 10 mL	100 Doses	16666B

Nac No.

10032728